Analytical Data
-
Gene name
NAP1L1
- Application
-
Alternative Names
NAP1; NAP1L; NRP; NAP-1-related protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55209
-
Expression Region
Ala2~Thr289
-
Molecular Weight
40kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NAP1L1 (nucleosome assembly protein 1-like 1) is a multifunctional protein involved in various cellular processes, including chromatin assembly, gene regulation, and stress response. It belongs to the NAP family, which is known for its role in the formation and remodeling of chromatin structures, facilitating the proper packaging of DNA into nucleosomes. The study of recombinant NAP1L1 proteins has gained significance in the field of molecular biology, particularly in understanding the mechanisms underlying chromatin dynamics and gene expression regulation. Recent research has highlighted NAP1L1's involvement in development and differentiation, as well as its potential implications in diseases such as cancer, where chromatin reorganization plays a critical role in tumor progression. By utilizing recombinant technology to produce NAP1L1, researchers can investigate its structural characteristics, functional properties, and interactions with other chromatin-associated proteins. This approach not only enhances our understanding of NAP1L1's biological roles but also opens avenues for therapeutic interventions targeting chromatin dysregulation. Studies employing recombinant NAP1L1 can facilitate the development of novel strategies for modulating gene expression patterns in various clinical contexts, thereby contributing to advancements in precision medicine and regenerative therapies.
